ConductScience.org, home

Gene · 2621

NIH grants2,018

NIH grants whose papers are about the gene, through NIH's grant-paper links.

1,181 to 1,200 of 2,018

Download this page as JSON
GrantTitleGAS6 papersNewest fiscal year
R01CA181605Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer12018
R01CA183074A p53/NFkB-mediated metabolic mechanism for chemotherapy protection12018
R01CA183974Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer12018
R01CA187090The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci12018
R01CA188048Investigating a novel glutamine metabolism pathway in pancreatic cancer12018
R01CA188430Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer12018
R01CA196631A network platform to connect drug response and prognosis phenotypes for cancers12018
R01DK018024Novel Secreted Kinases12018
R01DK078897Cellular and molecular mechanisms of retinoids in podocytes12018
R01DK098126SIRT1 Sirtuin in Diabetic Kidney Disease12018
R01DK101251Vitamin A Homeostasis: Retinyl Ester Stores12018
R01DK102624p90 Ribosomal S6 Kinase and Chronic Kidney Disease12018
R01GM036652Microfilament Organization and Regulation12018
R01GM083025Kinase-dependent Regulation of Metabolic Enzymes12018
R01GM095567Mechanisms of Selective Autophagy12018
R01GM132069TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef12018
R01HG008383EFFICIENT SPECTRAL APPROACHES FOR FINDING UNDERLYING STRUCTURES IN BIG DATA12018
R01HG008927Computational Methods for Genome-Wide CRISPR Screens12018
R01HL115232Myeloid cell interactions in atherosclerosis12018
R01HL119047miR-33 Pathway Inhibition for Improving HDL Functionality12018

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2621/grants?page=60